-
KAZUHIKO KINTAKA, KONOMI HAIBARA, MITSUKO ASAI, AKIRA IMADA
1981 Volume 34 Issue 9 Pages
1081-1089
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
A novel β-lactam antibiotic, isosulfazecin (iSZ), was found to be produced by an acidophilic pseudomonad,
Pseudomonas mesoacidophila sp. nov. iSZ was produced in parallel with bacterial growth in nutrient broth containing glycerol and sodium thiosulfate under aerated conditions. iSZ was isolated by chromatography on activated charcoal and anion-exchangers and crystallized from 70% aqueous methanol. The molecular formula was determined to be C12H20N4O9S from physicochemical data. The IR and NMR spectra suggested that iSZ has a β-lactam ring, methoxyl and sulfonate groups. On acid hydrolysis, it gave L-alanine and Dglutamic acid. iSZ is an epimeric isomer of sulfazecin. iSZ was weakly active against Grampositive and -negative bacteria, and was strongly active against mutants hypersensitive to β-lactam antibiotics.
View full abstract
-
II. ISOLATION, STRUCTURE AND CHEMICAL DEGRADATION
KAZUNORI OHBA, TAKASHI TSURUOKA, KAZUKO MIZUTANI, NORIKO KATO, SHOJI O ...
1981 Volume 34 Issue 9 Pages
1090-1100
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
A new aminoglycoside antibiotic, dactimicin produced by a
Dactylosporangium matsuzakiense SF-2052 has been isolated by column chromatography on a cation-exchange resin and CM-Sephadex. The structure of dactimicin was determined to be 4-amino-1, 4-dideoxy- 3 - O - (2, 6 - diamino-2, 3, 4, 6, 7 -pentadeoxy- β- L -
lyxo-heptopyranosyl)-1-[(N-formimidoylglycyl)- methylamino]-6-O-methyl-L-
chiro-inositol. Alkaline hydrolysis of dactimicin afforded 1-
N -(N
-formylglycyl)fortimicin B, fortimicin B, fortimicin A and an acyl migration product, 2'-N-(N-formylglycyl)fortimicin B.
View full abstract
-
FERMENTATION, ISOLATION, CHARACTERIZATION AND BIOLOGICAL PROPERTIES
J. ALLAN WAITZ, ANN C. HORAN, MANOHAR KALYANPUR, BONG K. LEE, DAVID LO ...
1981 Volume 34 Issue 9 Pages
1101-1106
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
A novel antibiotic complex has been isolated from the fermentation broth of a new species of
Actinomadura, A. kijaniata SCC 1256. The complex was separated from the broth by a solvent extraction procedure and consists of 1 major component, designated kijanimicin, and 3 minor components. Kijanimicin was isolated from the complex by column chromatography and/or preparative high pressure liquid chromatography. Structurally the compound is a unique, large acid enol antibiotic and possesses an unusual
in vitro spectrum of activity against some Gram-positive and anaerobic microorganisms. In
vivo it has also shown interesting activity against malaria.
View full abstract
-
ISOLATION AND CHARACTERIZATION OF NIPHITHRICINS A, B, AND ELAIOPHYLIN, ANTIBIOTICS PRODUCED BY STREPTOMYCES VIOLACEONIGER
H.-P. FIEDLER, W. WÖRNER, H. ZÄHNER, H. P. KAISER, W. KELLER ...
1981 Volume 34 Issue 9 Pages
1107-1118
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
Fermentations of
Streptomyces violaceoniger TÜ 905 produce the antifungal antibiotics niphithricins A, B, elaiophylin and nigericin. The niphithricins have been characterized as new macrolide antibiotics, and the previously unknown structure of elaiophylin was determined to be a macrodiolide. The niphithricins were biologically active against Gram-positive bacteria and fungi. The mode of action is attributed to an alteration of the membrane permeability.
View full abstract
-
IMPROVED PRODUCTION AND ISOLATION, CHARACTERIZATIONAND ANTITUMOR ACTIVITY
DAVID G. MARTIN, CAROLYN BILES, SHIRLEY A. GERPHEIDE, LADISLAV J. HANK ...
1981 Volume 34 Issue 9 Pages
1119-1125
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
( Received for publication June 15, 1981)CC-1065 (NSC 298223) is a potent new antitumor antibiotic with a unique structure produced by
Streptomyces zelensis. Improved production, isolation, and assay methods are described along with physico-chemical properties and antitumor activity.
View full abstract
-
(STUDIES ON ANTIBIOTICS FROM THE GENUS BACILLUS. XXIX)1)
JUN'ICHI SHOJI, TOSHIYUIKI KATO, YOHKO YOSHIMURA, KAZUO TORI
1981 Volume 34 Issue 9 Pages
1126-1136
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
Thiocillins I, II and III were compared with micrococcin P1 by analysis of acid hydrolyzates of the native and the reduced antibiotics as well as by means of 1H and 13C NMR spectroscopies. As a result of these studies, the differences of these antibiotics were clarified in their structural units, and the structures of thiocillins I. I I and III were assigned on the basis of the proposed structure of micrococcin P1.
View full abstract
-
AKIHIRO TANAKA, AZUMA WATANABE, REIKO KOBAYASHI, TSUTOMU TSUCHIYA, SUM ...
1981 Volume 34 Issue 9 Pages
1137-1151
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
Derivatives of josamycin and isojosamycin modified at C-9 and C-13 have been prepared by reaction sequences involving treatment of josamycin with alcohols, phenol or 1-methyl-1
H-tetrazol-5-ylthiol in acidic media. Several tetrahydro derivatives of josamycin and isojosamycin have also been prepared by reaction sequences involving catalytic hydrogenation. From the 1H NMR studies, it was found that the conformation of the macro-lactone portion of 13-
O-methylisojosamycin dimethylacetal, a key intermediate, is flexible and changeable with variation of the solvent.
View full abstract
-
CHIKAHIRO URAKAWA, HARUKO TSUCHIYA, KIN-ICHI NAKANO, NOBUO NAKAMURA
1981 Volume 34 Issue 9 Pages
1152-1156
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
A new naturally occurring mitomycin, 10-decarbamoyloxy-9-dehydromitomycin B (
1), was prepared by treating mitomycin B with sodium hydride. Its analogs having an exo-cyclic double bond in their structure were also synthesized. These compounds showed antibacterial and cytotoxic activities. Among them, 7-amino-l0-decarbamoyloxy-9-dehydro-7-demethoxymitomycin B (
2) was the most potent growth inhibitor of KB cells in
vitro and, accordingly, it appears to be a potential antitumor agent.
View full abstract
-
PETER W. K. WOO
1981 Volume 34 Issue 9 Pages
1157-1163
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
The 2-methoxypropan-2-yl group fulfills the need of a hydroxyl protecting group generally suitable for the synthesis of β-lactam antibiotics, satisfying the criteria of low-cost, convenience and selectivity in formation, and, above all, ease of deprotection under conditions compatible to the highly sensitive β-lactam function and without contamination of the final products. The use of this protecting group has enabled the successful attachment of 6-[4-(
N-acetyl-4-hydroxyl-L-prolylamino)phenyl]-1, 2-dihydro-2-oxo-3-pyridinecarboxyl group, through an amide linkage, to amoxicillin, cephaloglycin, and the 3-[[(1-carboxymethyl)-1-
H-tetrazol-5-yl]thio]methyl analogue of the latter, yielding broad-spectrum antibiotics with notably good activities against strains of
Pseudomonas aeruginosa.
View full abstract
-
TEIZO MURATA, SHINZABURO MINAMI, KENJI YASUDA, SHIZUKO IYOBE, MATSUHIS ...
1981 Volume 34 Issue 9 Pages
1164-1170
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
Cephalosporin β-lactamase (cephalosporinase; CSase) was purified from a strain of
Pseudomonas aeruginosa resistant to β-lactam antibiotics. The purified enzyme preparation gave a single protein band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and its molecular weight was about 34, 000. The specific activity was 49.7 μmoles/minute/mg of protein of the purified enzyme for the hydrolysis of cephaloridine. The optimal pH and optimal temperature were about 8.0 and 40°C, respectively. Its isoelectric point was 8.7. The enzyme activity was inhibited by iodine, some divalent ions, and some semisynthetic β-lactam antibiotics, including cephamycin derivatives such as moxalactam and YM09330. Mouse antiserum obtained against the purified enzyme showed no cross-reaction with other types of β-lactamase in neutralization test.
View full abstract
-
J. STEFAN ROKEM, LAURENCE H. HURLEY
1981 Volume 34 Issue 9 Pages
1171-1174
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
Streptomyces refuineus, the microorganism which produces the DNA reactive antibiotic anthramycin, has been shown to possess a quite specific mechanism to survive and grow in the presence of this antibiotic. Stationary phase cells are insensitive to anthramycin since the antibiotic is prevented from entering these cells. However, cells in early log phase are inhibited by concentrations of anthramycin that are later produced by these same cells. Significantly, sibiromycin, a closely related antibiotic, is taken up by cells of
S. refuineus independent of the age of the culture. Anthramycin reacts
in vitro equally as well with DNA isolated from
S. refuineus and other procaryotic and eucaryotic cells. When
S. refuineus has reached the production phase the anthramycin is probably biosynthesized outside the cell membrane which also becomes specifically impermeable to anthramycin.
View full abstract
-
KUNIMOTO HOTTA, HIROKAZU YAMAMOTO, YOSHIRO OKAMI, HAMAO UMEZAWA
1981 Volume 34 Issue 9 Pages
1175-1182
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
Streptomyces kanamyceticus ISP5500,
S. fradiae ISP5063 and
S. griseus ISP5236, which produce kanamycin, neomycin or streptomycin respectively, were highly resistant to the antibiotics they produced. Polyphenylalanine synthesis in cell free systems was also resistant to the action of the antibiotics. Reciprocal exchange between ribosomes and 5150 fractions from the three strains revealed that the S150 fraction of each strain had an enzyme activity that inactivated the appropriate antibiotic whereas the ribosomes were susceptible to the antibiotics. It was concluded that the resistance of the
in vitro polyphenylalanine synthesizing systems of these antibiotics was due to the presence of inactivating enzymes. Furthermore,
S. fradiae and
S. kanamyceticus were highly resistant to aminocyclitol-containing aminoglycoside antibiotics other than those produced by the two strains. In these cases, the inactivating enzymes were found to have a major role in the resistance mechanism. However, the resistance of
S. kanamyceticus ISP5500 to streptomycin seems to be due to resistance at the ribosomal level.
View full abstract
-
MASANORI SUGIYAMA, HIROSHI MOCHIZUKI, OSAMU NIMI, RYOSAKU NOMI
1981 Volume 34 Issue 9 Pages
1183-1188
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
The influence of streptomycin (SM) on protein synthesis in a SM-producing strain was investigated using polyuridylic acid-directed polyphenylalanine synthesis in cell-free extracts. Tolerance of protein synthesis to SM developed with increasing culture age of cells and could be attributed to a decrease in affinity of the ribosomes for SM and an increase in SM 6-kinase activity in the cells. SM 6-phosphate produced from SM by SM 6-kinase did not bind to ribosomes and, furthermore, ribosome-bound SM was effectively released on phosphorylation with SM 6-kinase. Also a decrease in cell permeability to SM during the production phase may contribute in protecting protein synthesis from the antibiotic.
View full abstract
-
JUN HAGINAKA, TERUMICHI NAKAGAWA, YUKIKO NISHINO, TOYOZO UNO
1981 Volume 34 Issue 9 Pages
1189-1194
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
An ion pair reversed phase HPLC method for the determination of clavulanic acid has been developed. Since clavulanic acid had poor absorption (λmax 201 nm in water) in a UV-region suitable for HPLC detection, the detectability was enhanced by bathochromic shift of λmax due to solvent effect. The shifts of λmax, were measured with the solutions containing clavulanic acid, tetrabutylammonium bromide, and phosphate buffer salts in aqueous methanol. The magnitudes of the observed shifts were investigated with respect to pH, ionic strength, methanol content, and TBAB concentration. The results indicated that TBAB concentration was the predominant factor responsible for the bathochromic shifts. Taking account of the results together with solvent effects on the retention of clavulanic acid on hydrophobic stationary phase, HPLC condition suitable for detection and separation of clavulanic acid in urine was established as follows; mobile phase: 10 mm TBAB+0.6 mM NaH2PO4+0.4 mM Na2HPO4 in H2O-MeOH, 10:1 (v/v) (pH 7.02), flow rate: 1.5 ml/minute, stationary phase: LiChrosorb RP-18 (25 cm×4.6 mm i.d.), detection: UV 220nM. The applicability of the present method is demonstrated by determining the time course of urinary excretion of clavulanic acid after oral administration of a conjugated tablet of clavulanic acid and amoxicillin to human subject.
View full abstract
-
HIDEHIKO SUZUKI, HIROMI KATO, NAOKO NAKANO, SABURO YANO, TSUNEHIRO KIT ...
1981 Volume 34 Issue 9 Pages
1195-1199
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
We have developed a competitive enzyme immunoassay (EIA) using co-polymer of styrene and maleate as the solid phase and glutaraldehyde for binding of the antibody to the solid phase. This assay showed a striking efficacy in its use for the assay of tobramycin (TOB). Furthermore, the pharmacokinetics of TOB were studied in six healthy male volunteers after the administration of 60- or 90-mg doses intramuscularly.
View full abstract
-
YOSHIKAZU SUGIMOTO, TOSHIO NISHIMURA, HIDEO SUZUKI, NOBUO TANAKA
1981 Volume 34 Issue 9 Pages
1200-1205
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
Activities of marker enzymes for various cell components were studied with extracts of adriamycin-, aclacinomycin A- and bleomycin-resistant cells and with partially purified plasma membrane fraction of aclacinomycin A-resistant cells, in comparison with those of the parental cells. Alkaline phosphodiesterase and Na+-K+-ATPase activities were observed to alter in the drug-resistant sublines, but other enzymes showed similar activities in the resistant cells to those in the parental cells. Alkaline phosphodiesterase activities in all the resistant sublines were higher than that in the parental cells. Na+-K+-ATPase activities of anthracycline-resistant sublines were lower and that in bleomycin-resistant cell line was higher than that of the parental cells. The adriamycin-resistant cells exhibited the same level of alkaline phosphodiesterase activity with the aclacinomycin A-resistant cells: υmax was the same with, and the affinity was twice stronger than the parental cells. The bleomycin-resistant cells showed
ca. 30% υmax in comparison with the sensitive cells, and 17 fold higher affinity than the parental cells. The current results, concerning changes of membrane-associated enzymes in drug-resistant sublines of L5178Y cells, support the assumption that the resistance is due to alteration of plasma membrane transport systems.
View full abstract
-
TAKASHI TSURUO, KUNIKO NAGANUMA, HARUMI IIDA, TAKAO YAMORI, SHIGERU TS ...
1981 Volume 34 Issue 9 Pages
1206-1209
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
Bestatin, a chemically defined immunostimulant of low molecular weight, suppressed the gradually-occurring lymph node metastasis of P388 leukemia in CDF1 mice when administered i.p. at the doses of 1- 30μg/mouse. It could not, however, suppress the established large metastasis of P388 leukemia. Lymph node cells isolated from the mice given bestatin i.p. at 1 and 30μg/mouse showed stronger cytostatic activity against P388 leukemic cells
in vitro than those from the untreated mice.
View full abstract
-
HIDEO SUZUKI, TOSHIO NISHIMURA, NOBUO TANAKA
1981 Volume 34 Issue 9 Pages
1210-1212
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
-
HIDEHISA OKUBO, YOSHINORI ABE, MAKOTO HORI, HIDEKI ASAKURA, HAMAO UMEZ ...
1981 Volume 34 Issue 9 Pages
1213-1215
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
-
NOBUYOSHI SHIMADA, NAOMASA YAGISAWA, HIROSHI NAGANAWA, TOMOHISA TAKITA ...
1981 Volume 34 Issue 9 Pages
1216-1218
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
-
HIKARU NAKAMURA, NAOMASAY AGISAWA, NOBUYOSHSIH IMADA, TOMOHISA TAKITA, ...
1981 Volume 34 Issue 9 Pages
1219-1221
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
-
YAEKO KONDA, MASAYUKI ONDA, KIYOIZUMI HINOTOZAWA, SATOSHI OMURA
1981 Volume 34 Issue 9 Pages
1222-1223
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
-
MICHAEL J. BASKER, JOHN H. BATESON, ANDREW J. G. BAXTER, ROGER J. PONS ...
1981 Volume 34 Issue 9 Pages
1224-1226
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
-
MAKOTO TAMAKI, MICHIAKI TAKIMOTO, SHOSUKE SOFUKU, ICHIRO MURAMATSU
1981 Volume 34 Issue 9 Pages
1227-1228
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
-
TOSHIKAZU OKI, YUKIO TAKATSUKI, HIROYASU TOBE, AKIHIRO YOSHIMOTO, TOMI ...
1981 Volume 34 Issue 9 Pages
1229-1231
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
-
YUKIO SUGIURA, TADASHI SUZUKI, YASUHIKO MURAOKA, YOJI UMEZAWA, TOMOHIS ...
1981 Volume 34 Issue 9 Pages
1232-1236
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS
-
YUKIHIKO KAMEDA, NAOKI ASANO, MASANORI TERANISHI, MICHIYO YOSHIKAWA, K ...
1981 Volume 34 Issue 9 Pages
1237-1240
Published: 1981
Released on J-STAGE: April 12, 2006
JOURNAL
FREE ACCESS